ATLAS Genomics is a CLIA-certified high complexity molecular diagnostic laboratory located in Seattle, WA. Our mission is providing the highest quality of testing, service, and technology as the physician’s top choice molecular specialty lab. We use Next-Generation Sequencing technology from Illumina® to provide the most current diagnostic testing services to the physician, with a focus on patient outcomes, physician-friendly reports and process, and the highest level of personal service for the clinic.
OUR MEDICAL DIRECTOR
Dr. Michael H. Kalnoski earned his Medical Degree (M.D.) from Saint Louis University School of Medicine. He completed his residency at the University of Washington in Clinical and Anatomic pathology and a fellowship in Hematology and is triple board certified. He also received post-graduate training (MBA) at Saint Louis University and San Francisco State University; post-graduate training in cell and molecular biology at the University of California, Los Angeles. Dr. Kalsnoski earned a B.A. in Chemistry from the University of Washington.
Dr. Kalnoski has an extensive background as a hospital-based pathologist and he has previously developed testing services for FISH, flow cytometry, genotyping, DNA sequencing, and microarray analysis of cancer. Dr. Kalnoski has also served as a medical director at several regional hospitals and large reference laboratories (Quest Diagnostics) in Washington and Alaska. Dr. Kalnoski is a recognized leader and molecular inspector for the College of American Pathology (CAP).